Respiratory Department, Dalian Women and Children's Medical Group, China.
Anal Cell Pathol (Amst). 2022 Aug 21;2022:4846336. doi: 10.1155/2022/4846336. eCollection 2022.
(RSV) infection is an important cause of hospitalization of children worldwide, leading to significant morbidity and mortality. RSV infection leads to increasing inflammatory and apoptosis events in the airway epithelium through mechanisms involving ROS generation. The antioxidant N-acetyl-L-cysteine (NAC) has been shown to inhibit influenza virus replication and to reduce the secretion of inflammatory and apoptotic mediators during virus infection. The study aims to investigate the effects of NAC on human bronchial epithelial cells BEAS-2B and HSPA6 expression during RSV infection. CCK-8 assays were performed to evaluate cell survival. The production of proinflammatory factors, TNF-, IL-6, IL-1, IL-18, and MUC5AC was examined by quantitative real-time PCR and ELISA. Oxidative stress was determined by reactive oxygen species (ROS), superoxide dismutase (SOD), malondialdehyde (MDA), and glutathione (GSH)/glutathione disulfide (GSSG) ratio. Immunoblotting analysis of epidermal growth factor receptor (EGFR) and its phosphorylation was performed. The antiviral effect of NAC was assessed by determining viral titers using plaque assay. RSV infection reduced cell survival, promoted the release of proinflammatory factors, increased the ROS production and MDA concentration, and diminished the SOD activity and GSH/GSSG ratio, all which were attenuated by NAC treatment. Accordingly, NAC treatment inhibited the activation of EGFR and MUC5AC in BEAS-2B cells with RSV infection. Furthermore, NAC administration resulted in a marked decrease in RSV-induced HSPA6 expression in BEAS-2B cells. Concomitantly, EPB treatment led to an evident inhibition of RSV fusion gene and viral replication in RSV-infected BEAS-2B cells. This work supports the use of NAC to exert antimucin synthesis, anti-inflammatory, antioxidant, and antiviral effects on airway epithelium during RSV infection.
(RSV) 感染是导致全球儿童住院的重要原因,导致发病率和死亡率显著增加。RSV 感染通过涉及 ROS 生成的机制导致气道上皮细胞中炎症和凋亡事件增加。抗氧化剂 N-乙酰-L-半胱氨酸 (NAC) 已被证明可抑制流感病毒复制,并在病毒感染过程中减少炎症和凋亡介质的分泌。本研究旨在探讨 NAC 对 RSV 感染人支气管上皮细胞 BEAS-2B 和 HSPA6 表达的影响。CCK-8 测定法用于评估细胞存活率。通过定量实时 PCR 和 ELISA 检测促炎因子 TNF-α、IL-6、IL-1、IL-18 和 MUC5AC 的产生。通过活性氧 (ROS)、超氧化物歧化酶 (SOD)、丙二醛 (MDA) 和谷胱甘肽 (GSH)/谷胱甘肽二硫化物 (GSSG) 比值测定氧化应激。进行表皮生长因子受体 (EGFR) 及其磷酸化的免疫印迹分析。通过噬斑测定法确定病毒滴度来评估 NAC 的抗病毒作用。 RSV 感染降低了细胞存活率,促进了促炎因子的释放,增加了 ROS 产生和 MDA 浓度,并降低了 SOD 活性和 GSH/GSSG 比值,所有这些都被 NAC 处理所减弱。因此,NAC 处理抑制了 RSV 感染 BEAS-2B 细胞中 EGFR 和 MUC5AC 的激活。此外,NAC 给药导致 RSV 诱导的 BEAS-2B 细胞中 HSPA6 表达明显减少。同时,EPB 处理导致 RSV 感染的 BEAS-2B 细胞中 RSV 融合基因和病毒复制明显抑制。这项工作支持在 RSV 感染期间使用 NAC 对气道上皮细胞发挥抗粘蛋白合成、抗炎、抗氧化和抗病毒作用。